Literature DB >> 21629515

Barrett's adenocarcinoma of the esophagus: better outcomes through new methods of diagnosis and treatment.

Angelika Behrens1, Oliver Pech, Florian Graupe, Andrea May, Dietmar Lorenz, Christian Ell.   

Abstract

BACKGROUND: Esophageal adenocarcinoma has attracted more attention among gastroenterologists recently because of its rapidly rising incidence in Western countries. Many new epidemiological findings have been published, and there have been numerous technical advances in diagnostic procedures and in multimodal treatment based on the staging of the disease.
METHODS: In this paper, we selectively review the literature on esophageal adenocarcinoma, also considering the evidence-based recommendations contained in the guidelines of the German Society for Digestive and Metabolic Diseases (Deutsche Gesellschaft für Verdauungs- und Stoffwechselkrankheiten, DGVS) as well as the latest data from our own research team. RESULTS AND
CONCLUSION: here have been major recent advances in the diagnosis and treatment of esophageal adenocarcinoma. New refinements in endoscopic techniques now make endoscopic treatment possible for early esophageal carcinoma. New surgical techniques and new strategies of neoadjuvant chemotherapy have lowered the morbidity and improved the outcome of patients with locally advanced disease. Molecular therapies, too, have shown promising initial results.

Entities:  

Mesh:

Year:  2011        PMID: 21629515      PMCID: PMC3103982          DOI: 10.3238/arztebl.2011.0313

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN: 1866-0452            Impact factor:   5.594


  38 in total

Review 1.  Management of nondysplastic Barrett's esophagus: where are we now?

Authors:  Prateek Sharma; Gary W Falk; Richard Sampliner; Stuart Jon Spechler; Kenneth Wang
Journal:  Am J Gastroenterol       Date:  2009-04       Impact factor: 10.864

2.  Advantage of endoscopic submucosal dissection compared with EMR for early gastric cancer.

Authors:  Shiro Oka; Shinji Tanaka; Iwao Kaneko; Ritsuo Mouri; Mayuko Hirata; Toru Kawamura; Masaharu Yoshihara; Kazuaki Chayama
Journal:  Gastrointest Endosc       Date:  2006-09-20       Impact factor: 9.427

3.  Endoscopic submucosal dissection for early gastric cancer: results and degrees of technical difficulty as well as success.

Authors:  A Imagawa; H Okada; Y Kawahara; R Takenaka; J Kato; H Kawamoto; S Fujiki; R Takata; T Yoshino; Y Shiratori
Journal:  Endoscopy       Date:  2006-10       Impact factor: 10.093

4.  Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis.

Authors:  Val Gebski; Bryan Burmeister; B Mark Smithers; Kerwyn Foo; John Zalcberg; John Simes
Journal:  Lancet Oncol       Date:  2007-03       Impact factor: 41.316

5.  Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age.

Authors:  Linda Morris Brown; Susan S Devesa; Wong-Ho Chow
Journal:  J Natl Cancer Inst       Date:  2008-08-11       Impact factor: 13.506

6.  The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection.

Authors:  Christian G Peyre; Jeffrey A Hagen; Steven R DeMeester; Nasser K Altorki; Ermanno Ancona; S Michael Griffin; Arnulf Hölscher; Toni Lerut; Simon Law; Thomas W Rice; Alberto Ruol; Jan J B van Lanschot; John Wong; Tom R DeMeester
Journal:  Ann Surg       Date:  2008-10       Impact factor: 12.969

7.  Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagus.

Authors:  O Pech; A Behrens; A May; L Nachbar; L Gossner; T Rabenstein; H Manner; E Guenter; J Huijsmans; M Vieth; M Stolte; C Ell
Journal:  Gut       Date:  2008-05-06       Impact factor: 23.059

Review 8.  Short and long-term advantages of transhiatal and transthoracic oesophageal cancer resection.

Authors:  J M T Omloo; S Y K Law; B Launois; E Le Prisé; J Wong; M I van Berge Henegouwen; J J B van Lanschot
Journal:  Eur J Surg Oncol       Date:  2008-11-17       Impact factor: 4.424

9.  Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial.

Authors:  Stefano Cascinu; Roberto Labianca; Carlo Barone; Armando Santoro; Carlo Carnaghi; Alessandra Cassano; Giordano D Beretta; Vincenzo Catalano; Oscar Bertetto; Sandro Barni; Luciano Frontini; Enrico Aitini; Silvia Rota; Valter Torri; Irene Floriani; Carmelo Pozzo; Lorenza Rimassa; Stefania Mosconi; Paolo Giordani; Antonio Ardizzoia; Paolo Foa; Carla Rabbi; Silvana Chiara; Giampietro Gasparini; Mario Nardi; Mauro Mansutti; Ermenegildo Arnoldi; Elena Piazza; Enrico Cortesi; Francesca Pucci; Rosa Rita Silva; Alberto Sobrero; Alberto Ravaioli
Journal:  J Natl Cancer Inst       Date:  2007-04-18       Impact factor: 13.506

10.  Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study).

Authors:  F De Vita; F Giuliani; M Orditura; E Maiello; G Galizia; N Di Martino; F Montemurro; G Cartenì; L Manzione; S Romito; V Gebbia; F Ciardiello; G Catalano; G Colucci
Journal:  Ann Oncol       Date:  2007-05-24       Impact factor: 32.976

View more
  9 in total

1.  [Endoscopic and surgical resection of mucosal adenocarcinoma in Barrett's esophagus : Comparison at two high-volume centers].

Authors:  L Haeder; J Jähne
Journal:  Chirurg       Date:  2012-01       Impact factor: 0.955

2.  Correspondence (reply): non sequitor.

Authors:  Angelika Behrens; Christian Ell
Journal:  Dtsch Arztebl Int       Date:  2012-01-20       Impact factor: 5.594

3.  Correspondence (letter to the editor): Prophylactic role of aspirin.

Authors:  Bernhard J Connemann
Journal:  Dtsch Arztebl Int       Date:  2012-01-20       Impact factor: 5.594

4.  The frequency of lymph node metastasis in early-stage adenocarcinoma of the esophagus with incipient submucosal invasion (pT1b sm1) depending on histological risk patterns.

Authors:  Hendrik Manner; Oliver Pech; Yvonne Heldmann; Andrea May; Michael Pauthner; Dietmar Lorenz; Annette Fisseler-Eckhoff; Manfred Stolte; Michael Vieth; Christian Ell
Journal:  Surg Endosc       Date:  2014-10-08       Impact factor: 4.584

Review 5.  Scoping out the future: The application of artificial intelligence to gastrointestinal endoscopy.

Authors:  Scott B Minchenberg; Trent Walradt; Jeremy R Glissen Brown
Journal:  World J Gastrointest Oncol       Date:  2022-05-15

6.  Multidisciplinary treatment of T1a adenocarcinoma in Barrett's esophagus: contemporary comparison of endoscopic and surgical treatment in physiologically fit patients.

Authors:  Henner M Schmidt; Kamran Mohiuddin; Artur M Bodnar; Mustapha El Lakis; Stephen Kaplan; Shayan Irani; Ian Gan; Andrew Ross; Donald E Low
Journal:  Surg Endosc       Date:  2015-11-05       Impact factor: 4.584

Review 7.  Endoscopic resection of gastric and esophageal cancer.

Authors:  Bryan Balmadrid; Joo Ha Hwang
Journal:  Gastroenterol Rep (Oxf)       Date:  2015-10-27

Review 8.  Diagnostics and Early Diagnosis of Esophageal Cancer.

Authors:  Volker Meves; Angelika Behrens; Jürgen Pohl
Journal:  Viszeralmedizin       Date:  2015-10-06

9.  Fluorescence characteristics of human Barrett tissue specimens grafted on chick chorioallantoic membrane.

Authors:  Jasmin A Holz; David F Boerwinkel; Sybren L Meijer; Mike Visser; Ton G van Leeuwen; Jacques J G H M Bergman; Maurice C G Aalders
Journal:  Lasers Med Sci       Date:  2015-12-04       Impact factor: 3.161

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.